These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 2273250)

  • 1. Kinetic immunochemical studies of IgG production during local and systemic anti-influenza immune response in rats.
    Kovatchev D; Karaivanova L; Bochnakova E
    J Hyg Epidemiol Microbiol Immunol; 1990; 34(3):323-8. PubMed ID: 2273250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro production of anti-influenza virus antibody after intranasal inoculation with cold-adapted influenza virus.
    Yarchoan R; Murphy BR; Strober W; Clements ML; Nelson DL
    J Immunol; 1981 Nov; 127(5):1958-63. PubMed ID: 7299119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TH cells primed during influenza virus infection provide help for qualitatively distinct antibody responses to subsequent immunization.
    Marshall D; Sealy R; Sangster M; Coleclough C
    J Immunol; 1999 Nov; 163(9):4673-82. PubMed ID: 10528164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human peripheral blood mononuclear cells produce IgA anti-influenza virus antibody in a secondary in vitro antibody response.
    Yarchoan R; Barrow LA; Kurman C; Strober W; Nelson DL
    J Immunol; 1985 Aug; 135(2):1033-9. PubMed ID: 3874224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific anti-influenza virus antibody production in vitro by human peripheral blood mononuclear cells.
    Yarchoan R; Murphy BR; Strober W; Schneider HS; Nelson DL
    J Immunol; 1981 Dec; 127(6):2588-94. PubMed ID: 6975330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the humoral and cellular immune responses at different immunological sites after split influenza virus vaccination of mice.
    Hauge S; Madhun AS; Cox RJ; Brokstad KA; Haaheim LR
    Scand J Immunol; 2007 Jan; 65(1):14-21. PubMed ID: 17212762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine.
    Greenbaum E; Engelhard D; Levy R; Schlezinger M; Morag A; Zakay-Rones Z
    Vaccine; 2004 Jun; 22(20):2566-77. PubMed ID: 15193382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
    Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
    J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design.
    Bessa J; Schmitz N; Hinton HJ; Schwarz K; Jegerlehner A; Bachmann MF
    Eur J Immunol; 2008 Jan; 38(1):114-26. PubMed ID: 18081037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti-influenza vaccine.
    Greenbaum E; Furst A; Kiderman A; Stewart B; Levy R; Schlesinger M; Morag A; Zakay-Rones Z
    J Med Virol; 2001 Sep; 65(1):178-84. PubMed ID: 11505461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunity to influenza in older adults with chronic obstructive pulmonary disease.
    Gorse GJ; O'Connor TZ; Newman FK; Mandava MD; Mendelman PM; Wittes J; Peduzzi PN
    J Infect Dis; 2004 Jul; 190(1):11-9. PubMed ID: 15195238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Circulating and secretory antibodies in mice after administration of influenza virus by various routes].
    Wilczyński J; Loza-Tulimowska M; Semkow R
    Med Dosw Mikrobiol; 1979; 31(4):239-44. PubMed ID: 544981
    [No Abstract]   [Full Text] [Related]  

  • 13. Protection against influenza virus infection by intranasal vaccine with surf clam microparticles (SMP) as an adjuvant.
    Ichinohe T; Watanabe I; Tao E; Ito S; Kawaguchi A; Tamura S; Takahashi H; Sawa H; Moriyama M; Chiba J; Komase K; Suzuki Y; Kurata T; Sata T; Hasegawa H
    J Med Virol; 2006 Jul; 78(7):954-63. PubMed ID: 16721854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The recombinant rabbit hemorrhagic disease virus VP60 protein obtained from Pichia pastoris induces a strong humoral and cell-mediated immune response following intranasal immunization in mice.
    Farnós O; Rodríguez M; Chiong M; Parra F; Boué O; Lorenzo N; Colás M; Lleonart R
    Vet Microbiol; 2006 May; 114(3-4):187-95. PubMed ID: 16384666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin-A antibodies in upper airway secretions may inhibit intranasal influenza virus replication in mice but not protect against clinical illness.
    Bizanov G; Janakova L; Knapstad SE; Karlstad T; Bakke H; Haugen IL; Haugan A; Samdal HH; Haneberg B
    Scand J Immunol; 2005 Jun; 61(6):503-10. PubMed ID: 15963044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against influenza virus infection by intranasal administration of hemagglutinin vaccine with chitin microparticles as an adjuvant.
    Hasegawa H; Ichinohe T; Strong P; Watanabe I; Ito S; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T
    J Med Virol; 2005 Jan; 75(1):130-6. PubMed ID: 15543590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local immune responses following nasal delivery of an adjuvanted influenza vaccine.
    Scheerlinck JP; Gekas S; Yen HH; Edwards S; Pearse M; Coulter A; Sutton P
    Vaccine; 2006 May; 24(18):3929-36. PubMed ID: 16540213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matching antibody class with pathogen type and portal of entry: cognate mechanisms regulate local isotype expression patterns in lymph nodes draining the respiratory tract of mice inoculated with respiratory viruses, according to virus replication competence and site of inoculation.
    Sangster MY; Mo XY; Sealy R; Coleclough C
    J Immunol; 1997 Aug; 159(4):1893-902. PubMed ID: 9257854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The IgG subclass responses to influenza virus haemagglutinin in the mouse: effect of route of inoculation.
    Hocart MJ; Mackenzie JS; Stewart GA
    J Gen Virol; 1989 Apr; 70 ( Pt 4)():809-18. PubMed ID: 2732707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.